{"id":23493,"date":"2023-11-07T12:37:50","date_gmt":"2023-11-07T20:37:50","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23493"},"modified":"2025-02-11T16:01:52","modified_gmt":"2025-02-11T23:01:52","slug":"kisqali-a-first-line-treatment-option-for-breast-cancer","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","title":{"rendered":"Kisqali: L\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u tay cho b\u1ec7nh ung th\u01b0 v\u00fa"},"content":{"rendered":"\n<p><span style=\"font-weight: 400;\">Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. It is considered a first-line treatment option. It is also effective in extending survival when combined with hormone therapy.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-d4c21770df5e14cf84909c4305e2c8a1\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tChemotherapy\u00a0Financial Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.novartis.com\/\">Novartis<\/a>, a Swiss multinational pharmaceutical company, developed Kisqali. It works by blocking specific enzymes that promote cancer cell division.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">The drug was discovered in the late 2000s as part of a research program to find inhibitors of cyclin-dependent kinases (CDKs). CDKs are enzymes involved in cell cycle regulation. Novartis recognized Kisqali&#8217;s potential as a cancer therapy and began clinical trials in breast cancer patients in 2013. In March 2017, the <a href=\"https:\/\/www.fda.gov\/\">FDA<\/a> approved the drug for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Later that year, the drug was approved for the same indication in Europe. The FDA expanded its approval to include premenopausal and perimenopausal women in July 2018.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Since its approval, Kisqali has become a great treatment option for advanced and metastatic breast cancer patients.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#What_Is_Kisqali_Used_To_Treat\" >What Is Kisqali Used To Treat?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#How_Kisqali_Works\" >How Kisqali Works<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Side_Effects\" >Side Effects<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Mild_Side_Effects\" >Mild Side Effects<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Serious_Side_Effects\" >Serious Side Effects<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Dosage_and_Treatment\" >Dosage and Treatment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Before_Taking_Kisqali\" >Before Taking Kisqali<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#Kisqali_Cost\" >Kisqali Cost<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-kisqali-used-to-treat\"><span class=\"ez-toc-section\" id=\"What_Is_Kisqali_Used_To_Treat\"><\/span>What Is Kisqali Used To Treat?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is a brand-name prescription drug used to treat an advanced type of breast cancer in women. It is used to treat breast cancer that has all the following properties [1]:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Metastatic or locally advanced:<\/b><span style=\"font-weight: 400;\"> Kisqali can treat breast cancer that is advanced (metastatic) or locally advanced. Metastatic means that the cancer has spread to different body parts, including the bones, liver, brain, and lungs. Locally advanced means that the cancer has spread to the breast area and structures, such as nearby lymph nodes, muscle, and skin, but not to other body parts.<\/span><\/li>\n\n\n\n<li><b>Hormone receptor-positive (HR-positive): <\/b><span style=\"font-weight: 400;\">Kisqali can help with hormone receptor positive (HR+) breast cancer.&nbsp;<\/span><\/li>\n\n\n\n<li><b>HER2-negative (HER2-): <\/b><span style=\"font-weight: 400;\">Kisqali can help with a type of breast cancer that does not have the human epidermal growth factor receptor (HER2-).<\/span><\/li>\n<\/ul>\n\n\n\n<p><b>Note:<\/b><span style=\"font-weight: 400;\"> Kisqali&#8217;s safety and effectiveness in children are unknown.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-kisqali-works\"><span class=\"ez-toc-section\" id=\"How_Kisqali_Works\"><\/span>How Kisqali Works<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is used to treat specific types of breast cancer. The active component in Kisqali is ribociclib. It works by inhibiting enzymes called CDK4 and CDK6. These enzymes regulate cell development in both cancerous and normal cells. These enzymes can become hyperactive in cancer cells, leading them to divide and grow uncontrollably. By blocking these enzymes, Kisqali can reduce or stop the growth of cancer cells in the body.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Like all medications, Kisqali can also cause side effects. In rare cases, it can also cause some severe side effects. The FDA has warned that Kisqali could cause fatal lung problems [7].&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Here are some mild to severe side effects [1]:<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-mild-side-effects\"><span class=\"ez-toc-section\" id=\"Mild_Side_Effects\"><\/span>Mild Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"268\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain.jpg\" alt=\"Woman with back pain as a side effect of taking Kisqali\" class=\"wp-image-23496\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-300x191.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-86x55.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-167x107.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-280x179.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/back-pain-370x236.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">The following are some of the most common mild side effects of using Kisqali:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Nausea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Back pain<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatigue<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vomiting<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrhea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Constipation<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Hair loss<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Low white blood cell counts<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Headache<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Most of these side effects may disappear within a few days or weeks. Consult your doctor or pharmacist if they become more severe or do not go away.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-serious-side-effects\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span>Serious Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">As stated earlier, serious side effects are rare but can occur. If you experience any of the listed serious side effects, contact your doctor immediately.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Serious side effects can include:<\/span><\/p>\n\n\n\n<p><b>Heart problems:<\/b><span style=\"font-weight: 400;\"> Kisqali can cause abnormal heartbeat, leading to death. Symptoms can include dizziness, fast heartbeat, faintness, and irregular heartbeat.<\/span><\/p>\n\n\n\n<p><b>Liver problems:<\/b><span style=\"font-weight: 400;\"> Severe liver problems can occur during treatment. Performing liver function tests before and during treatment is important. Symptoms of liver problems include loss of appetite, yellowing of your skin or the whites of your eyes, stomach pain, and dark urine.<\/span><\/p>\n\n\n\n<p><b>Lung problems:<\/b><span style=\"font-weight: 400;\"> You may encounter severe lung problems during Kisqali treatment, leading to death. Signs of the problem may be difficulty breathing, pain in the chest, and coughing.<\/span><\/p>\n\n\n\n<p><b>Low white blood cell counts: <\/b><span style=\"font-weight: 400;\">While using Kisqali, low white blood cell counts are common and can lead to dangerous infections.<\/span><\/p>\n\n\n\n<p><b>Severe skin problems:<\/b><span style=\"font-weight: 400;\"> You may experience a severe rash that progressively worsens. Symptoms can include red or flushed skin, peeling skin, blisters, fever, and body aches.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Please note that the list of side effects provided is not comprehensive. Seek immediate medical attention if you experience any severe side effects.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-85bcee098fb2173f8cc481ed1d37578b\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsult a Chemotherapy Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Treatment Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-and-treatment\"><span class=\"ez-toc-section\" id=\"Dosage_and_Treatment\"><\/span>Dosage and Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is available in a 200 mg tablet form. The duration of one treatment cycle is 4 weeks. During the first 3 weeks of the cycle, three tablets totaling 600 mg are administered once daily with or without food. After the 3-week period, there is a 1-week break before the next cycle begins.<\/span><\/p>\n\n\n\n<p><b>Note:<\/b><span style=\"font-weight: 400;\"> If severe side effects occur, your doctor can lower your dose or stop the treatment.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-before-taking-kisqali\"><span class=\"ez-toc-section\" id=\"Before_Taking_Kisqali\"><\/span>Before Taking Kisqali<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali should not be used if you are allergic to ribociclib or if you are also taking <a href=\"https:\/\/www.breastcancer.org\/treatment\/hormonal-therapy\/tamoxifen\">tamoxifen<\/a>. Your doctor will order blood tests to check that you do not have any issues that might prevent you from safely taking Kisqali.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">To ensure that the medication is safe for you, inform your doctor if you <\/span>have ever had:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Slow heartbeats<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">A history of heart disease or a previous heart attack<\/span><\/li>\n\n\n\n<li><a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/long-qt-syndrome-lqts#:~:text=Long%20QT%20syndrome%20(LQTS)%20is,fainting)%20or%20sudden%20cardiac%20death.\"><span style=\"font-weight: 400;\">Long QT syndrome<\/span><\/a><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Liver disease<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kidney disease<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Signs of infection (fever, chills)<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Also, let your doctor know if you&#8217;ve gone through menopause. You may need to have a negative pregnancy test before starting this treatment.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-kisqali-cost\"><span class=\"ez-toc-section\" id=\"Kisqali_Cost\"><\/span>Kisqali Cost<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">According to the official website, Kisqali tablets can cost around $6,000 to $15,000 per month, depending on your dose [5]. But the treatment&#8217;s actual cost depends on your insurance plan, location, and the pharmacy you visit. <a href=\"https:\/\/ameripharmaspecialty.com\/financial-assistance\/\">Contact us<\/a> if you are interested in copay or financial assistance.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-93b3f493ea3cfd0569ad91073d0ce290\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAbout Copay Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-faqs\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Here are answers to frequently asked questions about Kisqali:<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-kisqali-a-kind-of-chemotherapy\">Is Kisqali a kind of chemotherapy?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Yes. It is an oral <a href=\"https:\/\/ameripharmaspecialty.com\/conditions-treatments\/cancer\/\">chemotherapy<\/a> drug that signals cancer cells to stop growing.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-kisqali-safe-to-use-during-pregnancy\">Is Kisqali safe to use during pregnancy?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is not recommended during pregnancy because it could harm your unborn child. If you are a female of reproductive age taking Kisqali, you should take birth control during treatment and for 3 weeks after the last dosage. If you become pregnant while using this medicine, inform your healthcare provider immediately.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-is-it-safe-to-take-kisqali-while-breastfeeding\">Is it safe to take Kisqali while breastfeeding?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Breastfeeding is not recommended while using Kisqali. We don&#8217;t know if the medicine can pass into your breast milk. But if it does, breastfeeding infants are in danger of serious harm. You should not breastfeed while taking this medication and for 3 weeks after your final dosage because of this risk. Talk with your provider about other options for feeding your baby during therapy.&nbsp;<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-what-are-the-clinical-benefits-of-kisqali\">What are the clinical benefits of Kisqali?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Kisqali is a drug that is used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in women. It has some benefits over traditional treatments. Here are some clinical benefits of Kisqali:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">It can improve overall survival when used as a first-line treatment. According to a study, women treated with Kisqali and endocrine therapy lived about 1 year longer than women treated with endocrine therapy alone [8].<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">It can also improve progression-free survival. According to a study, women treated with Kisqali and <a href=\"https:\/\/www.webmd.com\/drugs\/2\/drug-4297\/letrozole-oral\/details\">letrozole<\/a> had 9 months of more progression-free survival than women treated with letrozole alone [8].<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kisqali can improve the quality of life for patients [9].<\/span><\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-can-kisqali-cause-me-to-lose-my-hair\">Can Kisqali cause me to lose my hair?<\/h4>\n\n\n\n<p>Possibly.<span style=\"font-weight: 400;\"> Hair loss is a very common side effect. Hair loss was reported in up to 33% of patients taking Kisqali in conjunction with other hormone treatments in studies [6]. If you are concerned about hair loss, talk with your provider.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kisqali l\u00e0 thu\u1ed1c u\u1ed1ng \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb m\u1ed9t s\u1ed1 lo\u1ea1i ung th\u01b0 v\u00fa ti\u1ebfn tri\u1ec3n ho\u1eb7c di c\u0103n. Kisqali \u0111\u01b0\u1ee3c coi l\u00e0 l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u tay. Thu\u1ed1c c\u0169ng c\u00f3 hi\u1ec7u qu\u1ea3 trong vi\u1ec7c k\u00e9o d\u00e0i s\u1ef1 s\u1ed1ng khi k\u1ebft h\u1ee3p v\u1edbi li\u1ec7u ph\u00e1p hormone.<\/p>","protected":false},"author":7,"featured_media":23495,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[8],"class_list":["post-23493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kisqali: A First-Line Treatment Option for Breast Cancer<\/title>\n<meta name=\"description\" content=\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kisqali: A First-Line Treatment Option for Breast Cancer\" \/>\n<meta property=\"og:description\" content=\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-07T20:37:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-11T23:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\",\"datePublished\":\"2023-11-07T20:37:50+00:00\",\"dateModified\":\"2025-02-11T23:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"},\"wordCount\":1243,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\",\"name\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"datePublished\":\"2023-11-07T20:37:50+00:00\",\"dateModified\":\"2025-02-11T23:01:52+00:00\",\"description\":\"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/breast-cancer-awareness.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Group of women wearing breast cancer awareness ribbons\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/cancer\\\/kisqali-a-first-line-treatment-option-for-breast-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kisqali: A First-Line Treatment Option for Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kisqali: L\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u tay cho b\u1ec7nh ung th\u01b0 v\u00fa","description":"T\u00ecm hi\u1ec3u v\u1ec1 Kisqali v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng thu\u1ed1c n\u00e0y \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 v\u00fa di c\u0103n. C\u00e1c ch\u1ee7 \u0111\u1ec1 bao g\u1ed3m c\u01a1 ch\u1ebf ho\u1ea1t \u0111\u1ed9ng, t\u00e1c d\u1ee5ng ph\u1ee5, li\u1ec1u d\u00f9ng v\u00e0 nhi\u1ec1u th\u00f4ng tin kh\u00e1c.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","og_locale":"vi_VN","og_type":"article","og_title":"Kisqali: A First-Line Treatment Option for Breast Cancer","og_description":"Learn about Kisqali and how it is used to treat metastatic breast cancer. Topics include how the drug works, side effects, dosage, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-11-07T20:37:50+00:00","article_modified_time":"2025-02-11T23:01:52+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"6 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Kisqali: A First-Line Treatment Option for Breast Cancer","datePublished":"2023-11-07T20:37:50+00:00","dateModified":"2025-02-11T23:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"},"wordCount":1243,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Cancer"],"inLanguage":"vi"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","url":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/","name":"Kisqali: L\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u tay cho b\u1ec7nh ung th\u01b0 v\u00fa","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","datePublished":"2023-11-07T20:37:50+00:00","dateModified":"2025-02-11T23:01:52+00:00","description":"T\u00ecm hi\u1ec3u v\u1ec1 Kisqali v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng thu\u1ed1c n\u00e0y \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 v\u00fa di c\u0103n. C\u00e1c ch\u1ee7 \u0111\u1ec1 bao g\u1ed3m c\u01a1 ch\u1ebf ho\u1ea1t \u0111\u1ed9ng, t\u00e1c d\u1ee5ng ph\u1ee5, li\u1ec1u d\u00f9ng v\u00e0 nhi\u1ec1u th\u00f4ng tin kh\u00e1c.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg","width":1280,"height":853,"caption":"Group of women wearing breast cancer awareness ribbons"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/cancer\/kisqali-a-first-line-treatment-option-for-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Kisqali: A First-Line Treatment Option for Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t AmeriPharma\u00ae","description":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t c\u1ee7a AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Ti\u1ebfn s\u0129 Christine Leduc, Ti\u1ebfn s\u0129 D\u01b0\u1ee3c","image":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"Ti\u1ebfn s\u0129 Christine Leduc, Ti\u1ebfn s\u0129 D\u01b0\u1ee3c, sinh ra v\u00e0 l\u1edbn l\u00ean t\u1ea1i Irvine, California. C\u00f4 theo h\u1ecdc t\u1ea1i \u0110\u1ea1i h\u1ecdc Midwestern, n\u01a1i c\u00f4 t\u1ed1t nghi\u1ec7p lo\u1ea1i xu\u1ea5t s\u1eafc. Ph\u1ea7n b\u1ed5 \u00edch nh\u1ea5t trong c\u00f4ng vi\u1ec7c c\u1ee7a c\u00f4 l\u00e0 \u0111\u1ec1 xu\u1ea5t thay \u0111\u1ed5i l\u1ed1i s\u1ed1ng, h\u01b0\u1edbng d\u1eabn b\u1ec7nh nh\u00e2n v\u1ec1 c\u00e1ch thu\u1ed1c c\u1ee7a h\u1ecd ho\u1ea1t \u0111\u1ed9ng v\u00e0 h\u01b0\u1edbng d\u1eabn c\u00e1c d\u01b0\u1ee3c s\u0129 t\u01b0\u01a1ng lai. L\u0129nh v\u1ef1c chuy\u00ean m\u00f4n c\u1ee7a c\u00f4 l\u00e0 d\u1ecbch v\u1ee5 kh\u00e1ch h\u00e0ng v\u00e0 ki\u1ebfn th\u1ee9c v\u1ec1 thu\u1ed1c chuy\u00ean khoa. T\u1eebng l\u00e0m vi\u1ec7c trong ng\u00e0nh d\u1ecbch v\u1ee5, c\u00f4 \u0111\u00e3 t\u00edch l\u0169y \u0111\u01b0\u1ee3c c\u00e1c k\u1ef9 n\u0103ng d\u1ecbch v\u1ee5 kh\u00e1ch h\u00e0ng c\u1ea7n thi\u1ebft \u0111\u1ec3 hi\u1ec3u nhu c\u1ea7u c\u1ee7a b\u1ec7nh nh\u00e2n. Ti\u1ebfn s\u0129 Leduc hi\u1ec7n \u0111ang h\u01b0\u1edbng d\u1eabn sinh vi\u00ean t\u1eeb \u0110\u1ea1i h\u1ecdc Marshall B. Ketchum, \u0110\u1ea1i h\u1ecdc Kansas v\u00e0 \u0110\u1ea1i h\u1ecdc Midwestern. Trong th\u1eddi gian r\u1ea3nh r\u1ed7i, c\u00f4 th\u00edch \u0111i du l\u1ecbch, l\u00e0m b\u00e1nh v\u00e0 l\u00e0m v\u01b0\u1eddn. Xem Ti\u1ec3u s\u1eed T\u00e1c gi\u1ea3","url":"https:\/\/ameripharmaspecialty.com\/vi\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. Kisqali is considered the first-line treatment option. It is also effective in extending survival when combined with hormone therapy.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/breast-cancer-awareness.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/vi\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/vi\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Kisqali is an oral medication used to treat certain types of advanced or metastatic breast cancer. Kisqali is considered the first-line treatment option. It is also effective in extending survival when combined with hormone therapy.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/23493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/comments?post=23493"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/posts\/23493\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media\/23495"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/media?parent=23493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/categories?post=23493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/vi\/wp-json\/wp\/v2\/tags?post=23493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}